Skip to main content

Table 3 Secondary outcomes

From: The effects of a limited infusion rate of fluid in the early resuscitation of sepsis on glycocalyx shedding measured by plasma syndecan-1: a randomized controlled trial

 

Standard rate (n = 48)

Limited rate (n = 48)

Point estimates (95% CI)*

p value

6-h lactate clearance (%)

(n = 46) 26.8 (39.8)

(n = 46) 26.4 (38.1)

Mean difference − 0.5% (− 16 to 15.6%)

0.95

Patients with MAP ≥ 65 mmHg at 1 h

36/47 (77%)

42/47 (89%)

RR 1.17(0.97–1.41)

0.049

Patients with MAP ≥ 65 mmHg at 6 h

43/47 (92%)

43/48 (90%)

RR 0.98(0.86–1.12)

0.73

P/F ratio at 6 h (mmHg)

(n = 46) 337 (178)

(n = 46) 363 (159)

Mean difference 26( − 44 to 96)

> 0.99

Fluid input in 6 h (ml)

(n = 47) 2600 (2100, 3489)

(n = 48) 2238(1898, 2488)

 

0.003

Fluid input per body weight in 6 h (ml/kg)

(n = 47) 53 (46, 64)

(n = 48) 39 (35, 52)

 

< 0.001

Fluid input per body weight in 24 h (ml/kg)

(n = 40) 115 (86, 146)

(n = 45) 88 (63, 111)

 

0.02

Fluid balance in 24 h (ml)

(n = 40) 3758 (1237, 4975)

(n = 43) 2896 (1520, 4535)

 

0.68

Fluid input per body weight in 72 h (ml/kg)

(n = 37) 175 (124, 220)

(n = 37) 150 (108, 229)

 

0.70

Fluid balance in 72 h (ml)

(n = 37) 3140 (377, 5524)

(n = 36) 4100 (2636, 7090)

 

0.13

Requirement for vasopressors

27/42 (64%)

20/46 (43%)

RR 0.68 (0.45–1.01)

0.05

Days alive and free from vasopressors up to 28 days

(n = 44) 26 (0, 28)

(n = 46) 27.5 (22, 28)

 

0.13

Requirement for mechanical ventilation

21/42 (50%)

19/46 (41%)

RR 0.83 (0.52–1.31)

0.41

Days alive and free from mechanical ventilation up to 28 days

(n = 44) 27.5 (0, 28)

(n = 46) 27 (9, 28)

 

0.91

Requirement for new RRT

4/42 (10%)

6/46 (13%)

RR 1.34 (0.41–4.52)

0.74

Days alive and free from RRT up to 28 days

(n = 44) 28 (0, 28)

(n = 46) 28 (21, 28)

 

0.60

Days alive and free from organ failure up to 28 days

(n = 44) 25 (0, 27.5)

(n = 46) 26 (9, 28)

 

0.37

Hospital LOS (day)

6 (5, 14)

11 (3.5, 25)

 

0.23

28-day mortality

12/48 (25%)

8/48 (17%)

RR 0.67 (0.30–1.48)

0.32

90-day mortality

15/48 (31%)

9/48 (19%)

RR 0.60 (0.29–1.24)

0.16

  1. Data are mean (SD), n/total n (%) and median (Q1, Q3)
  2. MAP mean arterial pressure, P/F PaO2/FiO2, RR relative risk, RRT renal replacement therapy, LOS length-of-stay
  3. *Point estimates are for the limited-rate group compared to the standard-rate group